Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for painful skin condition: drug trial targets stubborn HS

NCT ID NCT07287644

Disease control Sponsor: Bluefin Biomedicine, Inc. Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called BFB759 for people with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and abscesses. About 210 adults will receive either BFB759 or a placebo to see if the drug reduces the number of painful bumps and improves symptoms. The study lasts 36 to 40 weeks and aims to find a better treatment option for those whose HS is not well controlled by antibiotics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

About 210 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2025

Expected to finish

Aug 2027

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Are adults (18 to 75 years) with a diagnosis of hidradenitis suppurativa for at least one year. * Have moderate to severe disease not well controlled by systemic antibiotic treatment. * Are willing to follow study instructions, attend regular visits, and avoid certain other medications during the study. Exclusion Criteria: * Have certain infections or other immune conditions. * Recently used medications that could interfere with the study. * Are pregnant or breastfeeding.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hidradenitis suppurativa (HS) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hidradenitis suppurativa

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hidradenitis suppurativa (HS)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    58 sites in 7 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Apex Clinical Research Center, LLC

    RECRUITING

    Canton, Ohio, 44718, United States

  • Apex Clinical Research Center, LLC

    RECRUITING

    Mayfield Heights, Ohio, 44124, United States

  • CCR Ostrava s.r.o.

    RECRUITING

    Ostrava, Czechia

  • Center for Skin Science and Innovation

    RECRUITING

    Fort Lauderdale, Florida, 33308, United States

  • Clinical Science Institute

    RECRUITING

    Santa Monica, California, 90404, United States

  • Clinical Trials Management, LLC

    RECRUITING

    Tampa, Florida, 33607, United States

  • Clinical Trials Management, LLC

    RECRUITING

    Metairie, Louisiana, 70006, United States

  • Complejo Hospitalario Universitario de Pontevedra

    RECRUITING

    Pontevedra, Spain

  • DS Research of Kentucky

    RECRUITING

    Louisville, Kentucky, 40241, United States

  • DelRicht Research

    RECRUITING

    Atlanta, Georgia, 30329, United States

  • DelRicht Research

    RECRUITING

    New Orleans, Louisiana, 70115, United States

  • DelRicht Research

    RECRUITING

    Wildwood, Missouri, 63040, United States

  • DelRicht Research

    RECRUITING

    Mt. Pleasant, South Carolina, 29464, United States

  • DelRicht Research

    RECRUITING

    Smyrna, Tennessee, 37167, United States

  • DelRicht Research

    RECRUITING

    Prosper, Texas, 75078, United States

  • Dermatology Specialists of Spokane

    RECRUITING

    Spokane, Washington, 99202, United States

  • Encino Research Center

    RECRUITING

    Encino, California, 91436, United States

  • Equity Medical LLC

    RECRUITING

    The Bronx, New York, 10455, United States

  • Hospital Asil de Granollers

    RECRUITING

    Granollers, Spain

  • Hospital Gregorio Maranon

    RECRUITING

    Madrid, Spain

  • Hospital Universitario Virgen De Las Nieves

    RECRUITING

    Granada, Spain

  • Hospital Universitario de Gran Canaria Doctor Negrin

    RECRUITING

    Las Palmas de Gran Canaria, Spain

  • Hospital de Manises

    RECRUITING

    Valencia, Spain

  • JDR Dermatology Research LLC

    RECRUITING

    Las Vegas, Nevada, 89145, United States

  • Klinik und Poliklinik fur Dermatologie und Allergologie

    RECRUITING

    Munich, Germany

  • Luxderm Specjalistyczny Gabinet Dermatologiczny prof. dr hab. n. med. Dorota Krasowska

    RECRUITING

    Lublin, Poland

  • MI Skin Innovations

    RECRUITING

    Northville, Michigan, 48167, United States

  • Martha Stewart

    RECRUITING

    Mandeville, Louisiana, 70448, United States

  • Medical Center Etika Ambulatory For Specialized Outpatient Medical Care OOD

    RECRUITING

    Plovdiv, Bulgaria

  • Medical Center Medconsult Burgas EOOD

    RECRUITING

    Burgas, Bulgaria

  • Medical Center Medconsult Pleven OOD

    RECRUITING

    Pleven, Bulgaria

  • Medical Center Medconsult Pleven-Lovech Branch

    RECRUITING

    Lovech, Bulgaria

  • Medical Center Rusemed

    RECRUITING

    Rousse, Bulgaria

  • Medical Univ of SC Department of Dermatology

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • Melita Medical

    RECRUITING

    Wroclaw, Poland

  • NZOZ Specjal. Osrodek Dermatologiczny DERMAL

    RECRUITING

    Bialystok, Poland

  • North York Research Inc.

    RECRUITING

    Toronto, Ontario, M2N 3A6, Canada

  • Oakland Hills Dermatology

    RECRUITING

    Auburn Hills, Michigan, 48326, United States

  • Optima Research - Boardman

    RECRUITING

    Boardman, Ohio, 44512, United States

  • Pratia Pardubice a.s.

    RECRUITING

    Pardubice, Czechia

  • Saguaro Dermatology

    RECRUITING

    Phoenix, Arizona, 85008, United States

  • Sanatorium of Professor Arenbergera

    RECRUITING

    Prague, Czechia

  • Schweiger Dermatology, PC

    RECRUITING

    Hackensack, New Jersey, 07601, United States

  • Skin Cancer and Dermatology Institute

    RECRUITING

    Reno, Nevada, 89509, United States

  • Skin Care Research

    RECRUITING

    Boca Raton, Florida, 33021, United States

  • Southeast Research Specialist LLC

    RECRUITING

    Douglasville, Georgia, 30135, United States

  • St. Josef-Hospital Bochum

    RECRUITING

    Bochum, Germany

  • Stryde Research-Epiphany Dermatology

    RECRUITING

    Southlake, Texas, 76092, United States

  • The Indiana Clinical Trials Center, PC

    RECRUITING

    Plainfield, Indiana, 46168, United States

  • UPMC Department of Dermatology

    RECRUITING

    Pittsburgh, Pennsylvania, 15213, United States

  • Universitatsklinikum Frankfurt Klinik fur Dermatologie, Venerologie und Allergologie

    RECRUITING

    Frankfurt, Germany

  • University Clinic Dermatology Heidelberg

    RECRUITING

    Heidelberg, Germany

  • University Hospital, Leipzig

    RECRUITING

    Leipzig, Germany

  • University of Luebeck

    RECRUITING

    Lübeck, Germany

  • Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego we Wrocławiu

    RECRUITING

    Wroclaw, Poland

  • Wojewódzki Szpital Specjalistyczny we Wrocławi,Oddział Dermatologiczny

    RECRUITING

    Wroclaw, Poland

  • York Dermatology Clinical and Research Centre

    RECRUITING

    Richmond Hill, Ontario, L4B 1L1, Canada

  • Ziaderm Research LLC

    RECRUITING

    North Miami Beach, Florida, 33126, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.